Objective To investigate whether any of 14 serum and urine molecular markers (MMs) used
to monitor osteoarthritis (OA) would be associated with particular clinical end-points. Design …

For both economic and ethical reasons, identification of the optimal treatment for each
individual patient is a pressing concern, not only for the patients and their physician, but also …

Osteoarthritis (OA), also known as degenerative joint disease, is the most frequent chronic
musculoskeletal disease and the leading cause of disability in elderly persons. There are …

Osteoarthritis (OA) is a joint degenerative disease that most affects old age. The study of
proteomics in synovial fluid (SF) has the task of providing additional elements to diagnose …

Objective The purpose of this review is to describe highlights from original research
publications related to osteoarthritis (OA), epigenetics and genomics with the intention of …

Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects
more than 500 million population worldwide. OA was believed to be caused by the wearing …

Recent research in the field of osteoarthritis (OA) has focused on understanding the
underlying molecular and clinical phenotypes of the disease. This narrative review article …

The purpose of this review was to present highlights from the published literature on the
topic of the biology of osteoarthritis (OA). A PubMed search was conducted in order to locate …

Osteoarthritis is a syndrome affecting a variety of patient profiles. A European Society for
Clinical and Economic Aspects of Osteoporosis and Osteoarthritis and the European Union …

Osteoarthritis (OA), a disease affecting different patient phenotypes, appears as an optimal
candidate for personalized healthcare. The aim of the discussions of the European Society …